{
    "Trade/Device Name(s)": [
        "Liberty Normal Glucose Control"
    ],
    "Submitter Information": "Liberty Healthcare Group, Inc.",
    "510(k) Number": "K060706",
    "Predicate Device Reference 510(k) Number(s)": [
        "K001427",
        "K023657",
        "K011738",
        "K052980"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "April 28, 2006",
    "Summary Letter Received Date": "March 23, 2006",
    "Submission Date": "March 14, 2006",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [
        "Plastic bottle with dropper tip"
    ],
    "Instrument(s)/Platform(s)": [
        "Bayer Ascensia Microfill Blood Glucose Monitor",
        "Roche Accu-chek Active Blood Glucose Monitor",
        "LifeScan OneTouch Ultra Blood Glucose Monitor",
        "LifeScan OneTouch FastTake Blood Glucose Monitor"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Liberty Normal Glucose Control, a viscosity-adjusted glucose control solution for use with specified blood glucose monitors",
    "Indications for Use Summary": "For in vitro diagnostic use by healthcare professionals and people with diabetes mellitus to assess the performance of specified blood glucose monitors in home and clinical settings",
    "fda_folder": "Clinical Chemistry"
}